NCT02978963

Brief Summary

This case series aims to test the feasibility and acceptability of streamlined cognitive behavioral therapy (CBT) for adolescents with excessive worry. The treatment protocol focuses on reducing intolerance of uncertainty and the hypothesis is that this will help reduce worry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 13, 2016

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 1, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

December 22, 2017

Status Verified

December 1, 2017

Enrollment Period

8 months

First QC Date

November 13, 2016

Last Update Submit

December 20, 2017

Conditions

Keywords

Excessive worryWorryAdolescentsIntolerance of uncertainty

Outcome Measures

Primary Outcomes (1)

  • Penn State Worry Questionnaire for Children (PSWQ-C)

    Child and parent version

    At 12 weeks after treatment starts

Secondary Outcomes (10)

  • Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

    Baseline, 12 weeks after start of treatment and three month after treatment has ended.

  • Clinical Global Impression - Severity (CGI-S)

    Baseline, 12 weeks after start of treatment and three month after treatment has ended.

  • Clinical Global Impression - Improvement (CGI-I)

    At 12 weeks after start of treatment and three month after treatment has ended.

  • Children's Global Assessment Scale (CGAS)

    Baseline, 12 weeks after start of treatment and three month after treatment has ended.

  • Brief Intolerance of Uncertainty Scale (Brief IUS)

    Baseline, weekly during treatment, 12 weeks after treatment starts, and three months after treatment has ended

  • +5 more secondary outcomes

Study Arms (1)

Cognitive Behavioral Therapy

EXPERIMENTAL

All participants will receive cognitive behavioral therapy for excessive worry. Focus in treatment will be on reducing participants' intolerance uncertainty through in vivo and imaginary exposure to uncertainty inducing situations and thoughts. Treatment will also contain psycho education about anxiety and worry, as well as planning for maintenance of treatment gains. Parents of the participants will receive support and education about worry through an internet-delivered program.

Behavioral: Cognitive behavioral therapy

Interventions

CBT focused on reducing intolerance of uncertainty

Also known as: CBT
Cognitive Behavioral Therapy

Eligibility Criteria

Age13 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • A score on PSWQ-C of at least 22
  • Age between 13 and 17 years
  • Ability to read and write in Swedish
  • A parent or caregiver that is able to co-participate in the treatment
  • Participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

You may not qualify if:

  • Diagnosis of autism spectrum disorder, psychosis, bipolar disorder or severe eating disorder
  • Present risk of suicide
  • Ongoing substance dependence
  • Occurrence of domestic violence
  • Completed CBT for any anxiety disorder within the last 6 months (defined as at least 5 sessions of CBT including in vivo exposure sessions)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Stockholm, 171 77, Sweden

Location

MeSH Terms

Interventions

Cognitive Behavioral Therapy

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Eva Serlachius, MD, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

November 13, 2016

First Posted

December 1, 2016

Study Start

October 1, 2016

Primary Completion

June 1, 2017

Study Completion

October 1, 2017

Last Updated

December 22, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share

Locations